Europe, particularly France, is becoming less attractive to pharmaceutical companies conducting clinical trials due to excessive bureaucracy that delays processes, according to Leem (Les Entreprises du Médicament), an association representing the interests of pharmaceutical companies in France. After controversial decisions by US President Donald Trump in the scientific field, such as budget cuts and restrictions […]
The post Clinical Trials Are Fleeing Europe: What Needs to Change? first appeared on News Health.
Author : News Health
Publish date : 2025-03-28 07:13:00
Copyright for syndicated content belongs to the linked Source.